Neurology Grand Rounds: Lecanemab and Emerging Anti-Amyloid Therapies for the Treatment of Early Stage Alzheimer’s disease
Andrew Natonson, M.D., M.S., Assistant Professor of Neurology, Layton Aging & Alzheimer’s Disease Center, OHSU
| When |
September 27, 2023
8 a.m. to 9 a.m.
|
|---|---|
| Where |
|
| Contact Information |
About Neurology Grand Rounds
Neurology Grand Rounds provides free continuing medical education for the public. We strive to enable discussion that is both about and involves the patient so the physicians and providers can better understand complex neurologic conditions. In Grand Rounds, we explore the history of neurologic diseases and what can happen to improve care and treatment that they receive and to better explain and expand on how treatments should be approached and practiced by the clinician.
Target audience
Neurologists, Neurology residents and fellows, medical students, social workers, masters in administration, physician assistants, nurse practitioners, nurses and pharmacists. Additionally, Neurology Grand Rounds is open to the public.
Rounds schedule
Wednesdays, September through June
8–9 a.m.
See current schedule
Accessing Neurology Grand Rounds remotely
Our lectures are accessible remotely:
- Live stream: stream the meeting.
- Webex meeting: use this link if you plan to participate in the Q & A session. Ask your questions in the chat window.
Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit
OHSU School of Medicine, Division of CPD, designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.